Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

Rhea-AI Summary

Theratechnologies Inc. will report financial results and provide a business update for its first quarter on April 10, 2024. The call will be hosted by CEO Paul Lévesque and other key members of the management team.

MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its first quarter ended February 29, 2024, on Wednesday, April 10 at 8:30 a.m. ET.

The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below.

CONFERENCE CALL INFORMATION
Conference Call Date	April 10, 2024
Conference Call Time	8:30 a.m. ET
Webcast link	https://edge.media-server.com/mmc/p/pozhpvit
Dial in	1-888-513-4119 (toll free) or 1-412-902-6615 (international)
Access Code	4991919
CONFERENCE CALL REPLAY
Toll Free	1-877-344-7529 (US) / 1-855-669-9658 (Canada)
International Toll	1-412-317-0088
Replay Access Code	3783831
Replay End Date	April 17, 2024
To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html

An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). 

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800

 

FAQ

When will Theratechnologies Inc. report financial results for its first quarter in 2024?

Theratechnologies Inc. will report financial results for its first quarter on April 10, 2024.

Who will host the call for Theratechnologies Inc.'s financial results and business update?

The call will be hosted by Paul Lévesque, President and CEO of Theratechnologies Inc., along with other key members of the management team.

Where can participants find the webcast link for the conference call?

Participants can find the webcast link for the conference call at https://edge.media-server.com/mmc/p/pozhpvit.

How can participants access the conference call replay?

Participants can access the conference call replay by dialing 1-877-344-7529 (US) / 1-855-669-9658 (Canada) for toll-free access, or 1-412-317-0088 for international access. The replay access code is 3783831.